Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04VJQ
|
|||
| Former ID |
DNCL002944
|
|||
| Drug Name |
BVS857
|
|||
| Indication | Insulin-resistant disorder [ICD-11: 5A44; ICD-10: E10-E14] | Phase 1 | [1] | |
| Company |
Novartis Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01435330) Safety and Tolerability of BVS857 in Subjects With Insulin Resistance. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.